Stockscreener 앱 받기
22.36
1.06%
-0.24
Schrodinger Inc 주식(SDGR)의 최신 뉴스
Schrödinger to Announce Third Quarter 2026 Financial Results on November 4 - Business Wire
Certara, Inc. (CERT) Stock Price, News, Quote & History - Yahoo! Finance Canada
Up to 40% of lithium ions in battery fluid cluster. This could help guide battery design. - Stock Titan
Schrodinger (SDGR) Surges 7.6%: Is This an Indication of Further Gains? - Zacks Investment Research
Global Drug Discovery AI Tools MarketStrategic Forecast 2026-2032 | Generative AI, Cloud Platforms, and Integrated R&D Workflows Create New Growth Opportunities - GlobeNewswire Inc.
Biosimulation Market Set for Strong Growth Through 2035, Fueled by AI-Driven Drug Discovery, Virtual Trials and Precision Medicine Demand - GlobeNewswire Inc.
Early Warning Disclosure Regarding Common Shares of Irruptive Metals Corp. - Yahoo Finance
Schrodinger president Karen Akinsanya sells $927,970 in company stock By Investing.com - Investing.com Nigeria
Schrodinger president Karen Akinsanya sells $927,970 in company stock By Investing.com - Investing.com South Africa
Schrodinger president Karen Akinsanya sells $927,970 in company stock - Investing.com India
Options at $4.34 become shares sold near $30 for Schrodinger (SDGR) insider - Stock Titan
Schrodinger Insider Sold Shares Worth $927,970, According to a Recent SEC Filing - Yahoo Finance
Schrodinger president Karen Akinsanya sells $927,970 in company stock - Investing.com
Schrodinger Inc. (SDGR) Pulls Back 4.03% to $29.02, Nearing Key SupportCharm Flow - dars.gov.et
Host Digital Inc. Announces Common Stock Offering - Yahoo Finance
Insider at Schrodinger (NASDAQ: SDGR) plans September 2026 stock sale - Stock Titan
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Schrödinger Stock Adds 26% and $472 Million of Market Value; Tectora’s Terms Stay Private - TechStock²
Understanding the Setup: (SDGR) and Scalable Risk - Stock Traders Daily
Schrödinger introduces Tectora Therapeutics - BioWorld News
Tectora Therapeutics inc. announced that it has received $55 million in funding from New Enterprise Associates, Inc., RA Capital Management, L.P., Schrödinger, Inc. - marketscreener.com
Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation Programs - BioSpace
SDGR Looks 19.2% Undervalued on GF Value™ - GuruFocus
Schrodinger Establishes Tectora Therapeutics With RA Capital, New Enterprise Associates - marketscreener.com
A new drug company raises $55 million for oral medicines - Stock Titan
Is Schrodinger Inc (SDGR) a Bargain After 3.1% Drop? GF Value Sa - GuruFocus
Schrodinger (SDGR) Slips 1.3% as Shares Hold Above Key $19.58 SupportPut Flow Alert - dars.gov.et
Schrodinger (SDGR) Slips 1.3% as Shares Hold Above Key $19.58 SupportUp Down Volume - vinanet.vn
Can RXRX's Pipeline Expansion Strengthen Its Long-Term Growth Outlook? - TradingView
“Schrodinger’s Strait:” Why Hormuz Now Exists in a State of Permanent Uncertainty - Yahoo Finance
AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030 - PR Newswire
Schrödinger’s Strait - الحرة
Price-Driven Insight from (SDGR) for Rule-Based Strategy - Stock Traders Daily
Drug Discovery Platforms Market to Reach USD 16.5 Billion by 2036, Driven by AI-Powered Research and Rising Pharmaceutical R&D Investment - industrytoday.co.uk
Schrödinger to Present at Morgan Stanley Global Healthcare Conference 2026 - BioSpace
Schrödinger to Present at Morgan Stanley Global Healthcare Conference - Business Wire
Schrodinger Inc. (SDGR) Slips 1.81% to $20.04 as Stock Holds Above Key SupportInsider Selling Alerts - dars.gov.et
SDGR | Schrodinger, Inc. Common Stock FinancialsRevenue Breakdown - Quiver Quantitative
Schrödinger: The Software Business Is Stronger Than It Looks (NASDAQ:SDGR) - Seeking Alpha
Tejara Capital Ltd Takes $4.55 Million Position in Schrodinger, Inc. $SDGR - MarketBeat
Schrödinger (SDGR) Q2 2026 Earnings Call Transcript - AOL.ca
Schrodinger (NASDAQ:SDGR) Trading 10.4% HigherWhat's Next? - MarketBeat
BMO Capital Maintains Schrodinger(SDGR.US) With Buy Rating, Maintains Target Price $24 - Moomoo
Schrodinger Inc (SDGR) News, Articles, Events & Latest Updates - Stocktwits
The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci - Zacks Investment Research
The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci - Yahoo Finance
The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci - The Globe and Mail
Schrödinger-BMS collaboration centers on Bunsen for trillion-scale computational drug discovery - drugdiscoverytrends.com
Schrodinger Inc. (SDGR) Slides 4.7% to $17.59 as Bearish Momentum BuildsCounter Trend Trade - Vinanet
SDGR Looks 29.7% Undervalued on GF Value™ - GuruFocus
0.74%
0.53%
자본화:
|
볼륨(24시간):